Neuroscience
Alzheimer's roundup: Investigators carve out small gains against a brutal disease
Fierce Biotech
By John Carroll
July 18, 2013
- Alzheimer's Disease: Phase Ii Gammagard Findings
A report from the Alzheimer's Association International Conference (AAIC) in Vancouver: Alzheimer's drug IVIg could halt sufferers' decline Trial involving 16 patients excites scientists by suggesting treatment prevented deterioration of memory...
- Alzheimer's Association International Conference (aaic) 2012: Overview
Here is a link to the official AAIC Overview document: www.alz.org/aaic/downloads/aaic12_overview.pdf Here is the current schedule of press briefings (Pacific Time) for the conference, as cited on the conference website: Sunday, July 15 7:30 a.m. Gait...
- Neurodegenerative Disease Drug Discovery: Ucsf And Genentech
From Fierce Biotech: UCSF enters drug discovery agreement with Genentech Posted February 19, 2010 "The University of California, San Francisco has signed a partnership agreement with Genentech, Inc., a wholly owned member of the Roche Group, to discover...
- Business World: Myriad Genetics, Flurizan (mpc-7869), And Alzheimer Disease
From the AP, via Yahoo! News: Largest-Ever Alzheimer's Drug Trial Begins By PAUL ELIAS, AP Biotechnology Writer Sun Mar 12, 6:58 AM ET SAN FRANCISCO - It's tragedy enough that Pat Williams' mother...
- Business World: "the Brain Industry"
From The Seattle Times:Biotech Watch: Biotech companies scramble to develop brain-related products By Steve Johnson Knight Ridder Newspapers The Seattle Times Monday, July 25, 2005 SAN JOSE, Calif. — The prospect of a billion people nearing the age...
Neuroscience
Alzheimer's Disease: AAIC Review from "Fierce Biotech"
Alzheimer's roundup: Investigators carve out small gains against a brutal disease
Fierce Biotech
By John Carroll
July 18, 2013
Read the article
- Alzheimer's Disease: Phase Ii Gammagard Findings
A report from the Alzheimer's Association International Conference (AAIC) in Vancouver: Alzheimer's drug IVIg could halt sufferers' decline Trial involving 16 patients excites scientists by suggesting treatment prevented deterioration of memory...
- Alzheimer's Association International Conference (aaic) 2012: Overview
Here is a link to the official AAIC Overview document: www.alz.org/aaic/downloads/aaic12_overview.pdf Here is the current schedule of press briefings (Pacific Time) for the conference, as cited on the conference website: Sunday, July 15 7:30 a.m. Gait...
- Neurodegenerative Disease Drug Discovery: Ucsf And Genentech
From Fierce Biotech: UCSF enters drug discovery agreement with Genentech Posted February 19, 2010 "The University of California, San Francisco has signed a partnership agreement with Genentech, Inc., a wholly owned member of the Roche Group, to discover...
- Business World: Myriad Genetics, Flurizan (mpc-7869), And Alzheimer Disease
From the AP, via Yahoo! News: Largest-Ever Alzheimer's Drug Trial Begins By PAUL ELIAS, AP Biotechnology Writer Sun Mar 12, 6:58 AM ET SAN FRANCISCO - It's tragedy enough that Pat Williams' mother...
- Business World: "the Brain Industry"
From The Seattle Times:Biotech Watch: Biotech companies scramble to develop brain-related products By Steve Johnson Knight Ridder Newspapers The Seattle Times Monday, July 25, 2005 SAN JOSE, Calif. — The prospect of a billion people nearing the age...